Rational site-directed pharmacotherapy for major depressive disorder

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works

Research confuses me: what is the difference between case-control and cohort studies in quantitative research?

Higgins, S. M. F., Macken, A. P., Cullen, W., Saunders, J., Dunne, C. P., & O’Gorman, C. S. (2013) · PubMed · doi:10.34961/9953 · Cited by 4,806 · see citing works

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · see citing works

The Corticosteroid Receptor Hypothesis of Depression

Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181 · see citing works

The role of dopamine in the pathophysiology of depression

Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244 · see citing works

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

Schotte, A., Janssen, P. F. M., Gommeren, W., Luyten, W. H. M. L., Gompel, P. V., Lesage, A. S., Loore, K. D., & Leysen, J. E. (1996) · Psychopharmacology · doi:10.1007/bf02245606 · Cited by 1,167 · see citing works

Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression

Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052963 · Cited by 1,033 · see citing works

Medication Augmentation after the Failure of SSRIs for Depression

Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A. A., Lebowitz, B. D., Biggs, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052964 · Cited by 1,002 · see citing works

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939 · see citing works

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

Nelson, J. C., & Papakostas, G. I. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030312 · Cited by 552 · see citing works

Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action

Piñeyro, G., & Blier, P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01417-0 · Cited by 537 · see citing works

Is there a role for 5-HT1A agonists in the treatment of depression?

Blier, P., & Ward, N. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01643-8 · Cited by 529 · see citing works

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults

Kennedy, S. H., Lam, R. W. M., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 526 · see citing works

Molecular Neurobiology for Practicing Psychiatrists, Part 5: How a Leucine Zipper Can Turn On Genes: Immediate-Early Genes Activate Late-Gene Expression in the Brain.

Stahl, S. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0103 · Cited by 490 · see citing works

Variation in the Gene Encoding the Serotonin 2A Receptor Is Associated with Outcome of Antidepressant Treatment

McMahon, F. J., Buervenich, S., Charney, D. S., Lipsky, R. H., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Papanicolaou, G., Laje, G., D, M. F. M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503820 · Cited by 473 · see citing works

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.

Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431 · see citing works

Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study

Rush, A. J., Trivedi, M. H., Stewart, J. W., Nierenberg, A. A., D, M. F. M., Kurian, B. T., Warden, D., Morris, D. W., Luther, J. F., Husain, M. M., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111645 · Cited by 372 · see citing works

Neurochemical Characteristics of Amisulpride, an Atypical Dopamine D2/D3 Receptor Antagonist with Both Presynaptic and Limbic Selectivity

Schoemaker, H., Claustre, Y., Fage, D., Rouquier, L., Chergui, K., Curet, O., Oblin, A., Gonon, F., Carter, C. J., Bénavidès, J., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36395-5 · Cited by 371 · see citing works

Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report

McGrath, P. J., Stewart, J. W., D, M. F. M., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Thase, M. E., Davis, L. L., Biggs, M. M., Shores‐Wilson, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1531 · Cited by 350 · see citing works

Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive Disorder: A Meta-Analysis Including 6562 Patients

Szegedi, A., Jansen, W. T., van Willigenburg, A. P. P., van der Meulen, E., Stassen, H. H., & Thase, M. E. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.07m03780 · Cited by 341 · cited 1× · see citing works

Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1AReceptors

Haddjeri, N., Blier, P. U., & de Montigny, C. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-23-10150.1998 · Cited by 332 · see citing works

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

Porcelli, S., Fabbri, C., & Serretti, A. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.10.003 · Cited by 331 · see citing works

N-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-HT1A Agonist, as a Putative Mediator of Quetiapine's Antidepressant Activity

Jensen, N., Rodriguiz, R. M., Caron, M. G., Wetsel, W. C., Rothman, R. B., & Roth, B. L. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301646 · Cited by 319 · see citing works

Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study

Blier, P., Ward, H. E., Tremblay, P., Laberge, L., Hébert, C., & Bergeron, R. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020186 · Cited by 316 · see citing works

Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions

Guiard, B. P., Mansari, M. E., Merali, Z., & Blier, P. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008383 · Cited by 302 · see citing works

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

Abbas, A. I., Hedlund, P. B., Huang, X., Tran, T. B., Meltzer, H. Y., & Roth, B. L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1521-8 · Cited by 286 · see citing works

Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials

Dold, M., Aigner, M., Lanzenberger, R., & Kasper, S. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000740 · Cited by 211 · see citing works

Measurement of Endogenous Noradrenaline Release in the Rat Cerebral Cortex In Vivo by Transcortical Dialysis: Effects of Drugs Affecting Noradrenergic Transmission

L'Heureux, R., Dennis, T., Curet, O., & Scatton, B. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb08498.x · Cited by 191 · see citing works

Venlafaxine and paroxetine in treatment-resistant depression: Double-blind, randomised comparison

Poirier, M.-F., & Boyer, P. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.1.12 · Cited by 185 · see citing works

Clinical Effects of the 5-HT1A Partial Agonists in Depression

Robinson, D. S., Rickels, K., Feighner, J. P., Fabre, L. F., Gammans, R. E., Shrotriya, R. C., Alms, D. R., ANDARY, J. J., & MESSINA, M. E. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199006001-00013 · Cited by 172 · see citing works

Venlafaxine and paroxetine in treatment-resistant depression

Gregson, J. R. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.175.6.591a · Cited by 171 · see citing works

Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs

Nemeroff, C. B., Entsuah, R., Benattia, I., Demitrack, M. A., Sloan, D. M., & Thase, M. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.027 · Cited by 161 · see citing works

Mirtazapine and paroxetine in major depression: A comparison of monotherapy versus their combination from treatment initiation

Blier, P., Gobbi, G., Turcotte, J., de Montigny, C., Boucher, N., Hébert, C., & Debonnel, G. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.015 · Cited by 161 · see citing works

The Psychopharmacology of Energy and Fatigue

Stahl, S. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0102 · Cited by 159 · see citing works

Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats

Li, S. X.-M., Perry, K. W., & Wong, D. T. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00160-5 · Cited by 156 · see citing works

Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors

Szabo, S. T., de Montigny, C., & Blier, P. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001772 · Cited by 153 · see citing works

Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors

Blier, P. U., & de Montigny, C. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90107-1 · Cited by 149 · see citing works

Differential physiological effects of a low dose and high doses of venlafaxine in major depression

Debonnel, G., Saint-André, É., Hébert, C., de Montigny, C., Lavoie, N., & Blier, P. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006413 · Cited by 148 · see citing works

Bupropion occupancy of the dopamine transporter is low during clinical treatment

Meyer, J. H., Goulding, V. S., Wilson, A. A., Hussey, D. F., Christensen, B. K., & Houle, S. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1166-3 · Cited by 147 · see citing works

Effect of a selective 5‐HT reuptake inhibitor in combination with 5‐HT1A and 5‐HT1B receptor antagonists on extracellular 5‐HT in rat frontal cortex in vivo

Sharp, T., Umbers, V., & Gartside, S. E. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701235 · Cited by 136 · see citing works

Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area

Dremencov, E., Mansari, M. E., & Blier, P. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0930 · Cited by 135 · see citing works

Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs

Nemeroff, C. B., Entsuah, R., Benattia, I., Demitrack, M. A., Sloan, D. M., & Thase, M. E. (2010) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.8.4.foc592 · Cited by 126 · see citing works

Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons

Szabo, S. T., & Blier, P. U. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01583.x · Cited by 122 · see citing works

Synthesis and Structure−Activity Relationship in a Class of Indolebutylpiperazines as Dual 5-HT1A Receptor Agonists and Serotonin Reuptake Inhibitors

Heinrich, T., Böttcher, H., Gericke, R., Bartoszyk, G. D., Anzali, S., Seyfried, C. A., Greiner, H. E., & van Amsterdam, C. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040793q · Cited by 119 · see citing works

Assessment of the Serotonin and Norepinephrine Reuptake Blocking Properties of Duloxetine in Healthy Subjects

Turcotte, J. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00220-7 · Cited by 110 · see citing works

In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of α2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus

Mongeau, R., Blier, P. U., & de Montigny, C. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00167444 · Cited by 105 · see citing works

Clinical Assessment of Norepinephrine Transporter Blockade Through Biochemical and Pharmacological Profiles

Vincent, S., Bieck, P. R., Garland, E. M., Loghin, C., Bymaster, F. P., Black, B. K., Gonzales, C., Potter, W. Z., & Robertson, D. (2004) · Circulation · doi:10.1161/01.cir.0000130847.18666.39 · Cited by 102 · see citing works

Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons

West, C. H. K., Ritchie, J., Boss-Williams, K. A., & Weiss, J. M. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009474 · Cited by 100 · see citing works

Dopamine transporter availability in medication free and in bupropion treated depression: A 99mTc-TRODAT-1 SPECT study

Árgyelán, M., Szabó, Z., Kanyó, B., Tanács, A., Kovács, Z. Z. A., Janka, Z., & Pávics, L. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.08.016 · Cited by 98 · see citing works

Sustained Administration of Pramipexole Modifies the Spontaneous Firing of Dopamine, Norepinephrine, and Serotonin Neurons in the Rat Brain

Chernoloz, O., Mansari, M. E., & Blier, P. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.114 · Cited by 95 · see citing works

Bromocriptine and imipramine in endogenous depression

Wæhrens, J., & Gerlach, J. (1981) · Journal of Affective Disorders · doi:10.1016/0165-0327(81)90044-6 · Cited by 91 · see citing works

Do Substance P and the NK1 Receptor have a Role in Depression and Anxiety?

McLean, S. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764779 · Cited by 85 · see citing works

Serotonin 1A receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABAA receptors: A microiontophoretic study in the rat locus coeruleus

Szabo, S. T., & Blier, P. U. (2001) · Synapse · doi:10.1002/syn.10009 · Cited by 78 · see citing works

Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.

Lacroix, D., Blier, P., Curet, O., & de Montigny, C. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24669-9 · Cited by 77 · see citing works

Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report

McGrath, P. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.9.1531 · Cited by 77 · see citing works

Clinical Improvement With Fluoxetine Therapy and Noradrenergic Function in Patients With Panic Disorder

Coplan, J. D. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190069007 · Cited by 75 · see citing works

Effects of long-term treatment with the α2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission

Haddjeri, N., Blier, P. U., & de Montigny, C. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00004913 · Cited by 73 · see citing works

Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe

Dong, J., de Montigny, C., & Blier, P. U. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005055 · Cited by 67 · see citing works

Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers

Nichols, A. I., Focht, K., Jiang, Q. L., Preskorn, S., & Kane, C. P. (2011) · Clinical Drug Investigation · doi:10.2165/11586630-000000000-00000 · Cited by 66 · see citing works

Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain

El Mansari, M., Ghanbari, R., Janssen, S., & Blier, P. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.028 · Cited by 63 · see citing works

Focus on HTR2C: A possible suggestion for genetic studies of complex disorders

Drago, A., & Serretti, A. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30864 · Cited by 63 · see citing works

The Efficacy of Pramipexole, a Dopamine Receptor Agonist, as an Adjunctive Treatment in Treatment-Resistant Depression: An Open-Label Trial

Hori, H., & Kunugi, H. (2012) · The Scientific World Journal · doi:10.1100/2012/372474 · Cited by 62 · see citing works

Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder

Blier, P., & Blondeau, C. (2011) · Journal of Affective Disorders · doi:10.1016/s0165-0327(11)70003-9 · Cited by 55 · see citing works

Effect of Antidepressant Medication Treatment on Suicidal Ideation and Behavior in a Randomized Trial: An Exploratory Report From the Combining Medications to Enhance Depression Outcomes Study

Zisook, S., Lesser, I. M., Lebowitz, B., Rush, A. J., Kallenberg, G., Wisniewski, S. R., Nierenberg, A. A., Fava, M., Luther, J. F., Morris, D. W., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06724 · Cited by 55 · cited 1× · see citing works

Gepirone Extended-Release

Feiger, A. D., Heiser, J. F., Shrivastava, R. K., Weiss, K. J., Smith, W. T., Sitsen, J. M. A., & Gibertini, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0304 · Cited by 53 · see citing works

Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials

Maneeton, N., Maneeton, B., Srisurapanont, M., & Martin, S. D. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-160 · Cited by 51 · see citing works

Increased Tonic Activation of Rat Forebrain 5-HT1A Receptors by Lithium Addition to Antidepressant Treatments

Haddjeri, N. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00138-4 · Cited by 50 · see citing works

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report

Bobo, W. V., Chen, H., Trivedi, M. H., Stewart, J. W., Nierenberg, A. A., D, M. F. M., Kurian, B. T., Warden, D., Morris, D. W., Luther, J. F., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.04.032 · Cited by 50 · see citing works

Long-term administration of citalopram reduces basal and stress-induced extracellular noradrenaline levels in rat brain

Kawahara, Y., Kawahara, H., Kaneko, F., & Tanaka, M. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0826-8 · Cited by 50 · see citing works

Venlafaxine—mirtazapine combination in the treatment of persistent depressive illness

Hannan, N., Hamzah, Z., Akinpeloye, H. O., & Meagher, D. J. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107065738 · Cited by 42 · see citing works

Gepirone Extended-Release in the Treatment of Adult Outpatients With Major Depressive Disorder

Bielski, R. J., Cunningham, L. A., Horrigan, J. P., Londborg, P. D., Smith, W. T., & Weiss, K. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0408 · Cited by 41 · see citing works

Effects of Sustained Administration of Quetiapine Alone and in Combination with a Serotonin Reuptake Inhibitor on Norepinephrine and Serotonin Transmission

Chernoloz, O., Mansari, M. E., & Blier, P. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.18 · Cited by 39 · see citing works

Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain

Chernoloz, O., Mansari, M. E., & Blier, P. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110038 · Cited by 38 · see citing works

Pharmacological Profile of Antipsychotics at Monoamine Receptors: Atypicality Beyond 5-HT2A Receptor Blockade

Wood, M. D., Scott, C. M., Clarke, K. L., Cato, K. J., Patel, N. A., Heath, J., Worby, A., Gordon, L. J., Campbell, L. P., Riley, G. J., et al. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706777950693 · Cited by 36 · see citing works

Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion

Ghanbari, R., Mansari, M. E., & Blier, P. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2260-1 · Cited by 35 · see citing works

Effects of Race and Ethnicity on Depression Treatment Outcomes: The CO-MED Trial

Lesser, I. M., Zisook, S., Gaynes, B. N., Wisniewski, S. R., Luther, J. F., D, M. F. M., Khan, A., McGrath, P. J., Warden, D., Rush, A. J., et al. (2011) · Psychiatric Services · doi:10.1176/ps.62.10.pss6210_1167 · Cited by 35 · see citing works

The Impact of Chronic Depression on Acute and Long-Term Outcomes in a Randomized Trial Comparing Selective Serotonin Reuptake Inhibitor Monotherapy Versus Each of 2 Different Antidepressant Medication Combinations

Sung, S. C., Haley, C. L., Wisniewski, S. R., D, M. F. M., Nierenberg, A. A., Warden, D., Morris, D. W., Kurian, B. T., Trivedi, M. H., Rush, A. J., et al. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07043 · Cited by 33 · see citing works

Depression Treatment in Patients With General Medical Conditions: Results From the CO-MED Trial

Morris, D. W., Budhwar, N., Husain, M. M., Wisniewski, S. R., Kurian, B. T., Luther, J., Kerber, K. A., Rush, A. J., & Trivedi, M. H. (2012) · The Annals of Family Medicine · doi:10.1370/afm.1316 · Cited by 32 · see citing works

Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: An [11C]raclopride PET study

Egerton, A., Shotbolt, J. P., Stokes, P. R. A., Hirani, E., Ahmad, R., Lappin, J., Reeves, S., Mehta, M. A., Howes, O. D., & Grasby, P. M. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.077 · Cited by 31 · see citing works

Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report

Chan, H. N., Rush, A. J., Nierenberg, A. A., Trivedi, M., Wisniewski, S. R., Balasubramani, G. K., Friedman, E. S., Gaynes, B. N., Davis, L., Morris, D., et al. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001660 · Cited by 30 · see citing works

Long-term administration of monoamine oxidase inhibitors alters the firing rate and pattern of dopamine neurons in the ventral tegmental area

Chenu, F., Mansari, M. E., & Blier, P. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009218 · Cited by 30 · see citing works

Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties

Rauly‐Lestienne, I., Boutet-Robinet, E. A., Ailhaud, M., Newman‐Tancredi, A., & Cussac, D. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0182-6 · Cited by 29 · see citing works

A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.

Ad, F. (1996) · PubMed · Cited by 28 · see citing works

EFFECT OF CONCURRENT SUBSTANCE USE DISORDER ON THE EFFECTIVENESS OF SINGLE AND COMBINATION ANTIDEPRESSANT MEDICATIONS FOR THE TREATMENT OF MAJOR DEPRESSION: AN EXPLORATORY ANALYSIS OF A SINGLE-BLIND RANDOMIZED TRIAL

Davis, L. L., Pilkinton, P. D., Wisniewski, S. R., Trivedi, M. H., Gaynes, B. N., Howland, R. H., Zisook, S., Balasubramani, G. K., D, M. F. M., & Rush, A. J. (2012) · Depression and Anxiety · doi:10.1002/da.20918 · Cited by 22 · see citing works

A framework to avoid irrational polypharmacy in psychiatry

Zigman, D., & Blier, P. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112453211 · Cited by 16 · see citing works

Attributes of response in depressed patients switched to treatment with duloxetine

Sagman, D., McIntosh, D., Lee, M. S., Li, H., Ruschel, S. I., Hussain, N., Granger, R. E., Lee, A. C.-L., & Raskin, J. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02546.x · Cited by 15 · see citing works

The human 5-HT1A receptor: comparison of its binding properties in transfected cells and cortical tissue

Pou, C., Nénonéné, E. K., Reader, T. A., & Fargin, A. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)00257-7 · Cited by 8 · see citing works

Comparison of pramipexole, fluoxetine, and placebo in patients with major depression

(2000) · doi:10.1002/(sici)1520-6394(2000)11:2

Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders

Grinchii, D., & Dremencov, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249532 · Cited by 130 · see citing works

Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment

Fagiolini, A., Florea, I., Loft, H., & Christensen, M. C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.106 · Cited by 127 · see citing works

Neurotransmitter Targeting in the Treatment of Depression

Blier, P. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12084su1c.04 · Cited by 76 · see citing works

Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling

Ma, M., Ren, Q., Yang, C., Zhang, J.-C., Yao, W., Dong, C., Ohgi, Y., Futamura, T., & Hashimoto, K. (2016) · Scientific Reports · doi:10.1038/srep39209 · Cited by 58 · see citing works

Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity

Vahid-Ansari, F., Zhang, M., Zahrai, A., & Albert, P. R. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00404 · Cited by 59 · see citing works

Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting

Christensen, M. C., Fagiolini, A., Florea, I., Loft, H., Cuomo, A., & Goodwin, G. M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.099 · Cited by 52 · see citing works

Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine

Coutens, B., Yrondi, A., Rampon, C., & Guiard, B. P. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06203-8 · Cited by 43 · see citing works

Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment

Dold, M., Bartova, L., & Kasper, S. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa034 · Cited by 34 · see citing works

Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression

Gobbi, G., Ghabrash, M. F., Núñez, N. A., Tabaka, J. M., Sante, J. D., Saint-Laurent, M., Vida, S., Kolivakis, T., Low, N. C. P., Cervantes, P., et al. (2017) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000196 · Cited by 29 · see citing works

The discovery and development of vilazodone for the treatment of depression: a novel antidepressant or simply another SSRI?

Dawson, L. A. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.855195 · Cited by 18 · see citing works

A proposal for a psychopharmacology–pharmacotherapy catalogue of learning objectives and a curriculum in Europe

Baumann, P., Spies, M., Möller, H., Kasper, S. F., Bitter, I., & Laux, G. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2016.1149219 · Cited by 16 · see citing works

Sibutramine: efficacy and safety of prescribing in routine clinical practice

Romantsova, T. I. (2015) · Obesity and metabolism · doi:10.14341/omet2015318-24 · Cited by 12 · see citing works

Depression treatment by withdrawal of short-term low-dose antipsychotic, a proof-of-concept randomized double-blind study

Kennedy, S. H., Giacobbe, P., Placenza, F. M., Hudson, C. J., Seeman, P. M., & Seeman, M. V. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.014 · Cited by 9 · see citing works

Concurrent antipsychotic use in older adults treated with antidepressants in Asia

Dong, M., Zeng, L., Zhang, Q., Ungvari, G. S., Ng, C. H., Chiu, H. F. K., Si, T., Sim, K., Avasthi, A., Grover, S., et al. (2019) · Psychogeriatrics · doi:10.1111/psyg.12416 · Cited by 8 · see citing works

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial

Zuilhof, Z., Norris, S., Blondeau, C., Tessier, P., & Blier, P. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s175203 · Cited by 7 · see citing works

Dihydroergotamine and Bromocriptine: Potential Drugs for the Treatment of Major Depressive Disorder and Alzheimer’s Disease Comorbidity

Fu, M., Wang, Q., Gao, L., Ma, Q., & Wang, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04416-w · Cited by 4 · see citing works

Urgency to treat and early optimized treatment in major depressive disorder: consequences of delayed treatment, barriers to implementation, and practical strategies for clinicians

Oluboka, O. J., Habert, J., Khullar, A., Robinson, D. J., Katzman, M. A., Klassen, L. J., Soares, C., Chokka, P. R., Oakander, M. A., McIntyre, R. S., et al. (2025) · CNS Spectrums · doi:10.1017/s1092852925000276 · Cited by 3 · see citing works

Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple Sclerosis

Dolcetti, E., Annovazzi, P. O. L., Clerico, M., Cocco, E. E., Conte, A., Marfia, G. A., Salvetti, M., Tomassini, V., Clerici, V. T., Totaro, R., et al. (2024) · Current Neuropharmacology · doi:10.2174/011570159x326862240909105845 · Cited by 2 · see citing works

Emotional Blunting in Hong Kong Patients with Major Depressive Disorder Treated with Vortioxetine: A Naturalistic Observational Study

Kwan, Y. I. C., Fung, C. S., Lee, S. K. W., Lui, V. W. Y., & Cheng, C. P. W. (2026) · Biomedicines · doi:10.3390/biomedicines14020270 · Cited by 1 · see citing works

Les propriétés antidépressives de la kétamine

Desfossés, C. Y., & Blier, P. (2021) · médecine/sciences · doi:10.1051/medsci/2020256 · Cited by 1 · see citing works

Depressive Störungen

Laux, G. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_67 · Cited by 1 · see citing works

Neurobiological Bases of the Use of Atypical Antipsychotics in Treatment-Resistant Major Depressive Disorder

Kirby, J. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-21514

Training in Psychopharmacology-Pharmacopsychiatry for Residents in Psychiatry

Baumann, P. (2018) · Mental health and illness worldwide · doi:10.1007/978-981-10-0866-5_9-1

Depressive Störungen

Laux, G. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_67-1

Training in Psychopharmacology-Pharmacopsychiatry for Residents in Psychiatry

Baumann, P. (2019) · Mental health and illness worldwide · doi:10.1007/978-981-10-2350-7_9

Stratégies non pharmacologiques et réponse aux antidépresseurs dans un modèle murin de dépression : effets comportementaux et mécanismes neurobiologiques

Coutens, B. (2022) · theses.fr (ABES) · doi:10.70675/7ffbfd7ezefb5z4e4ez82f4z42a6ac0ff754

Troubles dépressifs et réponse thérapeutique : mécanismes d'action et modulation nutritionnelle par des actifs de safran (Crocus sativus L.).

de Oliveira, C. M. (2021) · theses.fr (ABES) · doi:10.70675/7291a4e5z9949z4fd4za27dze7f18385347b

Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder

Seo, R. J., MacPherson, H., & Young, A. H. (2010) · Pharmaceuticals · doi:10.3390/ph3123522 · Cited by 9 · see citing works

Relevance of Norepinephrine–Dopamine Interactions in the Treatment of Major Depressive Disorder

Mansari, M. E., Guiard, B. P., Chernoloz, O., Ghanbari, R., Katz, N., & Blier, P. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00146.x · Cited by 146 · see citing works

The under-recognized role of dopamine in the treatment of major depressive disorder

Montgomery, S. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282f2b3cb · Cited by 31 · see citing works

New Approaches to the Pharmacological Management of Major Depressive Disorder

Witkin, J. M., & Li, X. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57009-8 · Cited by 14 · see citing works

Multi-modality: a new approach for the treatment of major depressive disorder

Richelson, E. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001605 · Cited by 49 · see citing works